ANDOVER, Mass., June 4, 2015 /PRNewswire/ -- Philips
Respironics, a business of Royal Philips (NYSE: PHG AEX:
PHIA), today unveiled Alice NightOne, an at home sleep testing
system (HST). As the sleep lab industry adjusts to keep pace
with the demands of value-based care and changing reimbursement
requirements, Alice NightOne enables the efficient identification
and treatment of sleep disorder patients. Fully compatible
with the Philips Somnolyzer scoring solution, sleep technicians can
read the results from the Alice NightOne HST and determine a sleep
study score in 50-85 percent less time and with great
accuracy*.
"Conventional laboratory-based sleep testing or polysomnography
can pose challenges for sleep clinicians and patients, including
limited availability and cost," said Teofilo Lee-Chiong, M.D., Chief Medical Liaison,
Philips. "This latest, intuitive testing option allows reliable and
accurate diagnosis of sleep disordered breathing that is more
accessible and efficient. More importantly, it gives patients the
option of having a sleep test in the comfort of their own home,
which may improve overall patient experience and drive better
outcomes."
Speeding time to diagnosis and treatment
By
eliminating the long wait times for an appointment and discomfort
some patients associate with in-lab sleep studies, Alice NightOne
can speed the time to diagnosis and treatment. With minimal sensors
and intuitive icons, Alice NightOne is easy for patients to set up
themselves and limits discomfort while they sleep*. It
includes Smart Guide technology that provides step-by-step
instructions and feedback to ensure all functions are working
properly, reducing the chance of patient error. The device
indicates if additional testing may be required before the patient
returns the equipment, further streamlining logistics. Along with
enabling sleep technicians to identify an appropriate score
faster*, Alice NightOne also provides the data necessary to
differentiate between obstructive, central and positional sleep
apnea.
Connecting care across the sleep patient's journey
Alice NightOne is the latest in a suite of sleep disorder
diagnostic and treatment products from Philips that provide support
at every point along the sleep patient's journey. Philips
entire portfolio of sleep solutions is designed to connect care
across the health continuum and address the challenges patients and
clinicians face in diagnosis, adherence and long-term sleep therapy
compliance.
Alice NightOne will be on display at the Philips Respironics
booth (#601) at SLEEP 2015, the annual joint meeting of the
American Academy of Sleep Medicine and Sleep Research
Society. For more information on Philips' advanced solutions
for sleep and respiratory care, visit http://www.respironics.com/
and follow @PhilipsHealth.
For further information, please contact:
Alicia Cafardi
Philips
Tel: +1 724-387-4439
Email: alicia.cafardi@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA)
is a diversified health and well-being company, focused on
improving people's lives through meaningful innovation in the areas
of Healthcare, Consumer Lifestyle and Lighting. Headquartered in
the Netherlands, Philips posted
2014 sales of EUR 21.4 billion and
employs approximately 108,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions
and new lighting applications, as well as male shaving and grooming
and oral healthcare. News from Philips is located at
www.philips.com/newscenter.
* Data on file, Philips internal study
Logo -
http://photos.prnewswire.com/prnh/20140219/NE67640LOGO-b
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-debuts-alice-nightone-at-home-sleep-disorder-diagnostic-system-300094171.html
SOURCE Philips Respironics